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Abstract 
Nickel as a heavy metal is known to bring threat to human health, and its exposure is associated 
with changes in fibroblast activation which may contribute to its fibrotic properties. H2S has 
recently emerged as an important gasotransmitter involved in numerous cellular signal 
transduction and pathophysiological responses. Interaction of nickel and H2S on fibroblast cell 
activation has not yet been studied. Here, we showed that low dose nickel (200 µM) induced the 
activation of human fibroblast cells, as evidenced by 15% increase in cell growth, increased 
migration and higher expression of α-smooth muscle actin (αSMA) and fibronectin, while high 
dose of nickel (1 mM) inhibited cell viability. We further found that nickel repressed the mRNA 
and protein expression of cystathionine gamma-lyase (CSE, a H2S-generating enzyme) and 
blocked the endogenous production of H2S. Exogenously applied NaHS (a H2S donor) had no 
effect on nickel-induced cell viability but significantly attenuated nickel-stimulated cell 
migration and the expression of αSMA and fibronectin. In contrast, CSE deficiency deteriorated 
nickel-induced αSMA expression. Moreover, H2S incubation reversed nickel-stimulated 
TGFβ1/SMAD1 signal and blocked TGFβ1-initiated expressions of αSMA and fibronectin. 
Nickel inhibited the binding of Sp1 with CSE promoter but strengthened the binding of Sp1 with 
TGFβ1 promoter, which was reversed by exogenously applied NaHS. These data reveal that H2S 
protects from nickel-stimulated fibroblast activation and the CSE/H2S system can be a potential 
target for the treatment of tissue fibrosis induced by heavy metal. 
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1 Introduction 
 
1.1.  Hydrogen sulfide (H2S): the third gasotransmitter 
 
1.1.1 H2S sources and its effects 
There are two main sources for environmental H2S, organic and inorganic production. 
Organically produced H2S comes from bacteria and organic decomposition, the main sites for 
this type of production include sewers, septic tanks and water treatment plants (1). Inorganically 
produced H2S come from petroleum refineries, paper and pulp mills, and volcanos, etc (2). The 
human nose can sense H2S at low concentrations of 0.3 ppm to 1.5 ppm, at this concentration 
H2S is merely a scent nuisance (3). Clinical toxicological effects vary on length of exposure and 
concentration, H2S is instantaneously fatal at concentrations above 500-1000 ppm. Prolonged 
exposure to concentrations between 10 and 500 ppm can cause sore throat, wheezing, shortness 
of breath, chest tightness, and hemoptysis (4). The mechanism of H2S toxicity is related to its 
inhibition of oxidative phosphorylation (5). H2S inhibits cytochrome c oxidase, the last enzyme 
in the mitochondrial respiratory electron transport chain in aerobic oxidative metabolism causing 
the cessation of ATP production (6).  
 
1.1.2  H2S as a novel gasotransmitter  
Cellular signalling is often initiated by exogenous molecules binding to membrane receptors 
leading to intracellular messaging, there is a group of gases that are classified as exceptions (7). 
There are three gaseous signalling molecules identified thus far and they belong to the family 
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titled gasotransmitters (8). The three gasses are nitric oxide (NO), carbon monoxide (CO) and 
H2S. Gasotransmitters are classified if they follow the six criteria in Table 1.1.2 (9). 
Table 1.1.2     Gasotransmitter criteria  
1. They are small molecules of gas. 
2. They are freely permeable to membranes. As such, their effects will not rely on 
associated membrane receptors. 
3. They are endogenously and enzymatically generated and their generation is regulated. 
4. They have well-defined specific functions at physiologically relevant concentrations. 
5. Functions can be imitated by exogenous products. 
6. Their cellular effects may or may not be mediated by secondary messengers, but should 
have specific cellular and molecular targets.  
 
H2S is a colourless gas, which is flammable, lipid and water soluble and possesses a 
distinguishing rotten egg smell (10). H2S has a vapor density of 1.19 which is greater than air. 
H2S can be oxidized to form sulfates, elemental sulfur and sulfur dioxide (10). H2S has a short 
half-life in the air that varies from 12 to 37 hours with variables including temperature, humidity 
and pollutants (11). Half-life within the body is mere minutes, and the metabolites include 
thiosulfate, sulfite, and sulfate (8). At pH 7.4, one third of H2S remains undissociated while the 
remaining two thirds exist as anions (12). The following reaction (equation 1.1.2) represents the 
hydrolyzation of H2S: 
Equation 1.1.2     
 
1.1.3  Endogenous production of H2S 
Recent years have led to an overall accepted understanding of the endogenous H2S production 
but research must continue to understand the H2S signalling system and its role in disease 
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progression. One of the main biochemical means of H2S signalling is through S-sulfhydration 
(13). S-sulfhydration is the post translational modification of protein that occurs when H2S reacts 
with cysteine residues. The target proteins become modified into persulfide moieties (14). It is 
important to note that persulfide ligands have characteristics that are more favourable compared 
to thiols in the production of H2S. Persulfides are metastable and decompose into smaller 
molecules, they have a higher reactivity compared to thiols as they better nucleophiles, reducing 
agents and they react with electrophiles. Persulfides can be produced enzymatically and non-
enzymatically (14, 15).  
H2S is found at low concentrations of high nanomolar to low micromolar in circulation. H2S is 
endogenously produced by three enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase 
(CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST) through two pathways, pyridoxal-5’-
phosphate (P5P) co-factor dependent and P5P independent pathways (figure 1.1.3.1).  
 
Figure 1.1.3.1     Overview of H2S producing enzymes 
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CBS and CSE are localized in the cytoplasm while 3-MST is mainly localized to the 
mitochondrial matrix (16, 17). The production of the co-factor P5P comes from any of the 3 
forms of vitamin B6. The first most well-known pathway for endogenous H2S production is P5P 
dependent, used both by CSE and CBS enzymes (18). H2S production uses trans-sulfuration 
pathways, CBS is accountable for the first step of trans-sulfuration catalyzing homocysteine and 
serine to produce cystathionine (figure 1.1.3.2). CBS can also condense homocysteine and 
cysteine producing H2S (figure 1.1.3.3).  
 
Figure 1.1.3.2     First part of the transsulfuration pathway for homocysteine degradation  
 
Figure 1.1.3.3     CBS condenses homocysteine and cysteine or serine to produce H2S 
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The enzyme CSE is responsible for catalysing the second step of trans-sulfuration, cleaving 
cystathionine to produce L-cysteine, α-ketobutyrate and ammonia (figure 1.1.3.4) and then 
produce ammonium, pyruvate, serine and H2S (19). The P5P independent pathway uses the 
cysteine aminotransferase (CAT)/3-MST pathway (figure 1.1.3.5) (20). CAT uses cysteine and 
α-ketoglutarate to first produce 3-mercaptopyruvate. 3-MST then requires endogenous reducing 
substances such as thioredoxin (TRX) and dihydrolipoic acid (DHLA) to release H2S (19, 21). 
 
Figure 1.1.3.4     Second part of the transsulfuration pathway for homocysteine degradation 
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Figure 1.1.3.5     P5P independent production of H2S 
 
1.1.4  Implication of H2S in both health and disease  
Due to the current interest in understanding the roles of endogenous H2S, research has 
determined several benefits to H2S. There are three main biochemical means for direct H2S 
signalling. It can modulate protein cysteine residues in the process of persulfidation, also named 
S-sulfhydration, H2S can scavenge reactive oxygen species (ROS), and has the ability to react 
with proteins including proteins-containing metal centers (22, 23). Studies continue to scrutinize 
the role of H2S in many aspects of physiology observing the means for H2S direct interaction. 
Atherosclerosis, a leading cause of death in the developed world, is a chronic systemic disease 
that has been a focus in cardiovascular research (24). Many papers have shown the proper 
regulation of apoptosis has a defensive role in vascular protection in atherosclerosis disease 
states (25, 26). A study by Yang et al. demonstrated the important role of H2S in cellular 
apoptosis (27). Although perhaps seeming counterproductive, apoptosis is in fact vital for normal 
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multicellular development, impairment of apoptosis can lead to vascular defects during 
embryonic development resulting in embryonic death as well as the role apoptosis plays in the 
pathology of atherosclerosis (28). Studies have concluded that H2S induces apoptosis in human 
aortic smooth muscle cells through the activation of caspase-3 allowing normal vasculature 
development (28, 29).  
In addition, the role of H2S in cell proliferation has been observed; a study determined that H2S 
has the ability to inhibit cell proliferation and DNA synthesis during H2S overexpression. The 
study demonstrated that the enzyme producing H2S induced cyclin-dependent kinase inhibitors 
leading to cell cycle arrest (27). When researchers notice anti-proliferative effects, it is logical to 
question the agent’s role in cancer. A study looking at colon cancer observed that H2S can offer 
beneficial antiproliferative action in a colon cancer cell line (30).  
Another epidemic affecting western society is obesity, it is reported that obesity dramatically 
increases morbidity and mortality by increasing health complications such as cardiovascular 
disease, cancer, and type 2 diabetes (31, 32). A recent study, investigated the interaction of H2S 
on the pathways contributing to the regulation of adipogenesis, where cells differentiate into 
mature adipocytes. H2S was found to first increase differentiation, to cause changes to DNA 
binding and transcription factors, and to induce fat mass in both mouse and fly animal models 
(33). 
The role that H2S plays in diabetes has also been researched and it was found that H2S is 
increased in pancreatic cells emulating a diabetic state. The increased H2S production by 
enzymes causes a decrease in insulin levels (34, 35). A feedback loop begins as hyperglycemia 
inhibits H2S producing enzymes (34). It is also found that H2S can directly interact with a 
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glucose intermediate forming an H2S-glucose adduct that is not recognized by transporters or 
receptors (36). Diabetic patients have increased risks of other diseases and complications that 
H2S researchers have already focused on, including diabetic cardiomyopathy. The pathology of 
the disease includes myocardial hypertrophy, decreased cardiac contraction and an increase in 
extracellular matrix (ECM) proteins (37). Research in animal models focusing on the 
development of fibrosis, a hallmark of cardiomyopathy, have determined that H2S has a 
protective effect at physiological concentrations on cells that differentiate into myoblasts. The 
main cause of this activation is due to cytokines signalling cell damage and the requirement to 
repair damaged tissue (38, 39). A study done by Meng et al. found the slow releasing H2S 
molecule GYY4137 protects from myocardial fibrosis. Components of ECM and cellular 
proliferation were reduced by the treatment of exogenous GYY4137 via inhibiting the expression 
of transforming growth factor beta 1 (TGFβ1) and the SMAD pathway (40). This pathway is not 
yet fully understood and could be the key to understanding the protective role the H2S system has 
in tissue damage. 
 
1.1.5  H2S regulation of protein by sulfhydration 
A main cellular target of H2S is the ATP-dependent potassium (KATP) channel, H2S has been 
found to open the KATP channels specifically in vascular smooth muscles (41). The interaction of 
H2S with KATP leads to vasodilation, protection from ischemia-reperfusion injury and myocardial 
injury (13, 42, 43). H2S does not use a receptor to open the KATP channel but alters the channel 
by sulfhydration activating the channel by hyperpolarization (44, 45). The KATP channel is a 
heterooctomer comprising of equal numbers of pore-forming subunits (Kir6.x) and regulatory 
sulfonylurea receptors (SURx), at rest free thiols and disulfide bonds are at equilibrium and 
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when H2S is added, disulfide bonds break in the SUR subunits altering its functionality (46, 47). 
This target could highlight an underlying mechanism for the regulation of cellular respiration by 
H2S (48). In an in-depth review, Bibli et al. discussed H2S’s role in the cyclic guanosine 
monophosphate (cGMP) pathway. They found that fast releasing H2S donors increased cGMP 
levels by inhibiting phosphodiesterase and by increasing NO bioavailability and affecting eNOS 
S-sulfhydration (49). Another pathway that is important in this research and how H2S affects it, 
is the MAPK pathway (50). Many groups have determined that H2S has the ability to protect 
endothelial and cardiovascular cells by inhibiting the p38, ERK and JNK pathways (30, 50-52). 
Inhibiting these MAPK family kinases protects cells against damage due to high level of ROS, 
and ischemia/reperfusion induced cell apoptosis (51, 52). Next, Guo et al. determined that H2S 
has antioxidant effects by Keap1 S-sulfhydration leading to the activation of Nrf2 (51). Lastly, 
another target is the TGFβ receptor. In muscular and cardiac tissues, H2S has been shown to 
prevent the activation of the TGFβ1/SMAD pathway and attenuates the production of ECM 
components (40, 53).  
Proteins other than the three main H2S producing enzymes have the ability to S-sulfhydrate as 
well, these include glyceraldehyde 3-phosphate dehydrogenase (GAPDH), protein tyrosine 
phosphatase (PTP1B), PTEN, Cu/Zn superoxide dismutase (SOD) for example (54-56). The 
“sensor” sulfhydryl group binds to sulfane sulfur to regulate their enzyme activity through 
hydropersulfide formation (21). A study found that approximately 10 to 25% of endogenous 
GAPDH are sulfhydrated in vivo and the sulfhydration happens at the Cys150 position, the 
cysteine that is vital to its catalytic activity, and thus changes the activity of GAPDH (56). The 
next example, PTP1B, a key component in regulating many signal transduction pathways, was 
found to be inactivated by H2S through sulfhydration at the Cys215 position. A study determined 
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that the reaction occurs quickly, within two minutes of NaHS treatment (54). Another study 
tested PTEN as it is a main antagonist in a pathway responsible for the development of cancer. 
This protein is affected by sulfhydration at Cys124 after that, the protein undergoes a partial 
conversion with a disulfide bond between Cys124 and Cys71, this change renders the protein 
inactive (55). Lastly the protein Cu/Zn SOD can undergo a change to form a persulfide group at 
the exposed Cys111, this system is believed to be linked to primordial redox enzymes. The 
biological relevance of H2S metabolism in the SOD system still needs to be clarified (57). The 
regulation of S-sulfhydration levels and therefore the regulation of H2S is done by oxygen 
dependent catabolism through sulfide quinone oxidoreductase, sulfite oxidase and persulfide 
dioxygenase (58). The degradation of the persulfides is called desulfhydration and is assisted by 
a mitochondrial persulfide dioxygenase enzyme called ETHE1 (59). 
 
1.1.6  Quick and slow H2S releasing donors 
To supplement the production of H2S in laboratory settings, there are two types of H2S donors 
that can be used, fast and slow releasing compounds. Examples of slow releasing compounds 
include stable molecules such as GYY4137 and S-diclofenac or fast releasing compounds that 
include sodium sulfide (Na2S) or Lawesson’s reagent (10). The most common donor used in H2S 
related literature, even above H2S-bubbled solution, is sodium hydrosulfide (NaHS) a fast 
releasing compound in water (equation 1.1.6), this choice is due to reasons including the 
convenient preparation without the strong smell and the forward dissociation at relevant pH of 
~7.4. 
Equation 1.1.6     
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In conclusion, H2S was originally seen as a dangerous and toxic gas, as the study of H2S has 
progressed, H2S has been shown to have roles in anti-inflammation, cardio-protection, neuro-
protection, cytoprotection, as well as protection against oxidative stress (46, 60-63). Studies by 
groups like Zheng et al. have further shown cardiovascular benefits of H2S. They determined 
exogenous H2S will stop fibrotic response induced by hyperglycemia in cardiac fibroblasts (38). 
With the determination of positive protective abilities, it is important to further explore the 
beneficial effect of H2S, especially to further H2S research and observe other potential protective 
effects, including its protection against trace metals.  
 
1.2 Fibroblasts  
 
1.2.1  Fibroblast cell activation and fibrosis 
Fibroblast cells can be found all over the body, especially in the connective tissue, which 
connects and supports all tissues in the body. Fibroblast cells are normally quiescent with less 
proliferative and migratory property (64).  In response to cytokines or injury, fibroblast cells can 
be activated from its quiescent form to myofibroblasts, which start to proliferate, migrate, and 
secrete extracellular matrix proteins (ECM) (65). It is important to note that healthy normal 
tissue rarely comprise a population of myofibroblast cells (66). ECM contains components of 
structural proteins, ground substances, and adhesive proteins, including  collagen, glycoproteins, 
and fibronectin, etc. (67). The activation of fibroblasts to myofibroblasts permits the contraction 
of stress fibers through ECM to close and heal a tissue wound (66). Over-activation of fibroblasts 
will lead to tissue fibrosis. Other than fibroblast cells, smooth muscle cells, epithelial cells, 
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endothelial cells, fibrocytes and pericytes can also differentiate into myofibroblasts and 
contribute to tissue fibrosis (67). 
Fibroblasts have a few biological roles including wound healing, inflammation, angiogenesis and 
paracrine and autocrine signaling (68). Wound healing includes proliferation through 
chemotaxing, the activation of fibroblasts inducing cell contractions allow for wound closures, 
and can promote blood clotting (68, 69). Fibroblasts allow the accumulation of immune and 
inflammatory cells through the ground substance of ECM to the injury site. Fibroblasts secrete 
TGFβ1, some interleukins (IL), and ROS, they also help activate macrophages (70, 71). 
Angiogenesis that is beyond the reach of established blood vessels is essential and the ground 
substance of the ECM produced by fibroblast allows endothelial cells to migrate and build 
vessels (72). There are paracrine signaling molecules that act on fibroblasts released by myoblast 
precursor cells to induce ECM production, proliferation and differentiation. These molecules 
include platelet derived growth factor, IL-6 and IL-13 (73). IL-13 promotes TGFβ activation, and 
production along with other ECM components (74). After the initial paracrine signals onto 
fibroblast, the cells then produce paracrine signals, these include connective tissue growth factors 
and ROS further contributing to fibrotic responses (75). TGFβ is a signalling molecule that acts 
upon and is generated by fibroblasts in the differentiation to myofibroblasts, a few ILs have this 
quality as well (70, 73). Excessive activation or prolonged response to cellular injury leads to the 
pathological process of fibrosis causing scarring and eventual organ hardening and deformation, 
impairing organ function ultimately ending with organ failure leading to the advancement of 
many diseases (76).  
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1.2.2  TGFβ1/SMAD signalling and fibroblast activation 
Fibroblasts require chemical stimulation to differentiate into myofibroblasts, the activated cell 
will then secrete autocrine agents like TGFβ1 (73) and paracrine agents like ROS (75). TGFβ is 
one of the most potent pro-fibrotic cytokines involved in the differentiation of fibroblasts. There 
are three isoforms of the TGFβ protein, TGFβ 1, 2, and 3, that share three quarters homology in 
amino acid sequence. The protein TGFβ is a six cysteine knot motif with three disulfide bonds 
that stabilize β-sheets (77). TGFβ ligands are secreted from the fibroblasts in their latent 
precursor form; they are activated by proteolytical cleavage of the latency-associated peptide in 
the ECM. The activation of TGFβ involves conformational change by cleavage, physical 
interaction with other protein or endoglycosylases (78). 
Signal transduction in the TGFβ1/SMAD pathway begins with initial binding to a serine 
threonine kinase receptor. The receptor contains a cysteine rich extracellular region and kinase 
domains intracellularly (79). TGFβ binds to the type II receptor at the cell membrane, TGFβ1 
receptor would next be phosphorylated leading to the activation of kinase activity. The cascade 
will then lead to intracellular signalling (80). The SMAD proteins allow signalling from the 
receptor to the nucleus by phosphorylation of the SMAD family. Some SMAD proteins bind to 
DNA with simply a 5 base pair sequence recognition, while others do not bind to DNA directly 
(81). A group of SMAD components are actually inhibitory SMADs preventing the SMAD 
signalling by translocating into the nucleus and causing ubiquitination (82). The TGFβ1/SMAD 
signalling pathway is significant and it was found by cDNA/promoter testing that TGFβ1 acts 
upon sixty ECM related genes (83). The TGFβ1 promoter could be acting on the interaction 
between SMAD and specificity protein 1 (Sp1) (84). Sp1 is a zinc finger transcription factor that 
preferentially binds to GC-rich motifs. Studies have proved Sp1 plays a role in TGFβ1 and H2S 
14 
 
producing CSE genes (85, 86). Sp1 is important in the expression of ECM components like 
collagen, cytokines like TGFβ1 and interacts with SMAD, this makes it a target that interferes 
with pro-fibrotic activity and a factor to observe in the research of fibrosis (85).  
Exogenous TGFβ1 has the ability to improve wound healing; some research has shown that 
perhaps the SMAD pathway works by suppressing the inhibitory SMADs. In a study with 
SMAD inhibitors knocked out, exogenous TGFβ1 reversed the ECM effect indicating perhaps 
TGFβ1 works with a SMAD independent pathway (77). Thus the effects of TGFβ is mediated by 
intracellular signalling that include SMAD-dependent and SMAD-independent pathways (figure 
1.2.2). The independent pathway include mitogen activated protein kinases (MAPK) that have a 
role in cytokine and ECM gene expressions, migration and apoptosis (87). 
 
Figure 1.2.2     TGFβ activating on fibrotic pathways 
The TGFβ1/SMAD pathway is also involved in cross signalling mechanisms as some SMAD 
components have been seen to affect vitamin D3 induced transcription. Vitamin D receptors play 
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a role in cell proliferation and differentiation, apoptosis, and oxidative stress regulation (88). 
SMAD interacts with many transcript factors or co-factors like CBP/p300 by exposing the 
underlying DNA sequence to transcripts. Its interaction with Sp1 is likely a major reason for the 
role SMAD plays in transcriptional cross-talks, Sp1 is responsible for the transcription of many 
genes and the effects are dependent of the target promotors structure (89). The TGFβ1/SMAD 
pathway will induce targeted fibrotic gene expression of ECM components and therefore prove 
to be an important pathway in the understanding and prevention or protection of fibrotic diseases 
(77, 90). 
 
1.2.3  MAPK pathway and fibroblast cell activation 
The MAPK family is a group of threonine and serine protein kinases that play a role in signal 
transductions affecting gene expression. This family is separated into supplementary groups, the 
conventional sub-groupings are termed extracellular signal-regulated protein kinases (ERKs), c-
Jun N-terminal kinases (JNKs), and p38 (91). In mammals, fourteen MAPK proteins have been 
characterized, these are generally activated through phosphorylation and/or by the interaction 
with a small binding protein. The conventional MAPKs are composed of a set of sequential 
kinases:  MAPK, a MAPK kinase (MAPKK), and a MAPKK kinase (MAPKKK) (92). MAPKs 
respond to stress inducements or cytokines such as TGFβ1 and regulate differentiation, 
proliferation, cell survival, and apoptosis, all key factors in fibrosis progression (93). MAPK is 
collectively known to act as a downstream target of TGFβ1, inhibiting MAPK could prove to be 
a target for the progression of fibrosis (94). 
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1.2.4  αSMA and fibroblast cell activation 
Quiescent fibroblast cells are characteristically elongated and flat spindle-like shaped. 
Myofibroblasts are characterized as having a starburst shape, expressing alpha-smooth muscle 
actin (α-SMA), being contractile, producing and secreting ECM at a higher rate and becoming 
resistant to apoptosis (95). The actin fibers were originally thought to bundle and surround the 
wound in tissue injury as the first phase of healing followed by differentiation and proliferation 
of myofibroblasts (96). Later it was isometric tension testing in a collagen gel that highlighted 
contractile forces by α-SMA and ECM after wounding (97). ECM contains fibronectin, a protein 
that assists in the formation of connections between cells through integrin proteins (98), 
collagen, providing structural scaffolds for tissue regeneration (99) and α-SMA, fibers that 
function as contractile devices essential in cell migration (73). The ground substance of ECM is a 
proteoglycan gel allowing for nutrient flow past the reach of blood vessels, it also facilitates 
intercellular signalling and cell migration (67). 
 
1.2.5  MMP and fibroblast activation 
Fibroblasts are responsible for the breakdown and reabsorption of the produced ECM by matrix 
metalloproteinases (MMP), a protein that breaks down ECM to inhibit fibrotic effects. In 
contrast, other tissues such as bones have individual cells: osteoblasts to produce bones and 
osteoclasts that reabsorbs bone (67, 100). MMPs are a family of over 24 zinc-dependent 
endopeptidases that have the ability to degrading nearly all components of the ECM. Their 
ability to act upon ECM components make them vital in the process of tissue remolding (101). 
MMPs are expressed in enzymatically inactive states due to an interaction between a cysteine 
residue of the pro-domain with a zinc ion of the catalytic site. Only once this link is broken do 
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the MMPs become active (102). MMP-2 is one of the most common proteinases in the process of 
controlling ECM. Excessive levels of MMPs can damage the ECM network and affect essential 
tissue remodeling and signaling, a reduced level of MMPs would lead to accelerated progression 
of fibrosis (103).  
 
1.2.6  Treatment of tissue fibrosis 
Organs typically affected by fibrosis include the liver, kidney, heart, lungs, gastrointestinal tract 
and skin. These organs are altered due to different factors including autoimmune disorders, old-
age through progressive fibrosis or exposure to toxic agents (104, 105). There exists some 
therapies targeting fibroblast in treatments for fibrosis but with so many factors affecting 
myofibroblast differentiation, the single target treatments prove to be less effective than desired. 
For example an inhibitor of angiogenesis, endostatin, can act on fibroblasts but was originally 
clinically tried to be an anti-cancer agent acting on endothelial cells. Endostatins are peptides 
about 20 kDa, fragmented from the C terminus of collagen XVIII (106). A study by Yamaguchi 
and associates concluded that endostatins prevented and reversed the effects of TGFβ therefore 
suppressing the excessive production of ECM. The endostatin levels in serum are elevated and 
the groups hypothesized a negative feedback regulatory loop in preventing the progression of 
fibrosis (106, 107). Fibrocyte receptors are another therapeutic target that show potential in 
fibrosis treatments, the CXCR4 receptor is responsible for the facilitation of cell migration. The 
receptor is inhibited by caveolin 1, a caveolin peptide. It impedes the buildup of fibrocytes in the 
lungs of an animal model (108). 
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1.3   Metals 
 
1.3.1  Metal in human health  
The interaction of H2S with trace metals is also an increasingly researched topic and proves to be 
an interesting relationship to explore. Metals can be found almost everywhere in daily life and 
the overuse of the metals have had a huge impact in human health. Some metals at specific low 
concentrations like copper, iron, magnesium, nickel and zinc are regarded as essential nutrients 
for the body’s daily functions. Increasing the concentration of any of these trace metals 
significantly will lead to cell damage and disease. Industrial development and smelter related 
industries are the main sources of exposure of metal to the environment (109, 110).  
 
1.3.2  Nickel in human health 
Nickel, one of the trace metals, is mined mainly from sulfide ores and undergo processes 
involving fusion, heat and electrolysis for purification. One of the top countries that produce 
nickel in the world is Canada, with a large deposit located in the Sudbury basin in Ontario (111, 
112). Nickel is also widely found in air pollution, diesel exhaust or in a variety of industrial and 
consumer products, such as metal household items, jewellery, stainless steel, coins, cigarettes, 
and batteries, etc. In the clinical setting, nickel can be often found in the implantations of a metal 
stent or the use of nickel-chromium alloy occluder for treatments of cardiovascular disorders 
(109, 111, 113). As the population continues to have long term contact with nickel-containing 
consumer and clinical products, it is important to understand its risks to human health. Nickel is 
resistant to corrosion from water and air but easily dissolved in oxidizing acids (114). Nickel has 
an atomic number of 28 and is a transition metal with oxidation numbers of -1, 0, +1, +2, +3 and 
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+4 in compounds with Ni2+ being the most common. Nickel can be found in different forms that 
include elemental nickel, nickel oxide, nickel chloride, nickel sulfate, and nickel monosulfide 
(115, 116).  
Prolonged exposure to nickel by means of inhalation, ingestion or through dermal absorption can 
cause contact dermatitis, immunotoxicity, pulmonarytoxicity, neurotoxicity, genotoxicity, and 
carcinogenicity (117, 118). Many of the harmful effects of nickel arise from its interference with 
essential metal metabolisms such as zinc, magnesium or iron (114). Nickel crosses into the cell 
membrane through calcium channels and will compete for specific receptors with calcium (119). 
In metal-dependent enzymes, nickel can substitute for other trace metals, particularly zinc, 
altering the protein and ultimately the protein activity or function, this is seen in the Sp1 zinc 
finger transcription factor (118, 120). Nickel interacts with amino acids to form nickel 
complexes with cysteine, histidine and aspartic acid by its ability to bind to oxygen, sulfur and 
nitrogen side groups. Nickel has been found to have a better binding affinity for proteins 
compared to DNA, the affinity of DNA phosphate groups with nickel is less than that of the 
amino acid functional groups. Nickel in the cell is able to induce conformational transitions in 
oligodeoxynucleotides from the right-handed B helix to the left-handed Z helix (121). Previous 
studies have determined that nickel can induce DNA-protein crosslinks that will lead to the 
formation of ROS (120, 122). Nickel is excreted from the body through excrements and urine 
depending of the exposure route (121). Absorbed nickel is filtered in the kidney through the 
glomerulus and then low molecular weight nickel compounds are successively reabsorbed 
through capillary (123).  
Some organ systems are more sensitive to nickel toxicity including the respiratory system, 
cardiovascular system, and the kidneys. First the nose and throat area can become irritated, 
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especially in people suffering from asthma. Individuals with lung lesions or diseases can worsen 
their symptoms through inhaled pollution containing nickel (124). In the cardiovascular system, 
nickel can cause anemia and  increase blood pressure (125). Exposure to nickel induces kidney 
damage, increasing the formation of stones and leading to renal cancer (126). Nickel may also 
act directly on lipids and proteins as pro-oxidants or even as free radial generators. ROS are 
known to harm proteins, lipids, DNA and interfere with cellular signaling pathways. A schematic 
example of oxidant-mediated lung dysfunction due to higher level of nickel can be seen in figure 
1.3.2 (127). 
  
Figure 1.3.2     Oxidant-mediated inflammation 
 
1.3.3  H2S interacting with metals  
Sulfides have been used in histochemistry for over a century and a half, they transform the 
available metals like copper, iron, zinc, nickel, mercury, lead and arsenic in tissue to metal 
sulfites. An example of this type of histochemistry is the sulfide silver method testing where the 
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sulfites catalyze the reduction of silver ions binding the silver in place, permitting the analysis of 
these trace metals (128). Metalloproteins utilize oxygen, nitrogen and or sulfur from amino acid 
side chains like cysteine to bind the metal ion tightly, other more interactive protein ions can be 
generalized as highly exchangeable, mobile or labile (129, 130). For example zinc ions are 
mostly considered to be signalling molecules in inter/intra-cellular signalling therefore, a lot of 
labile zinc can be found inside the cells. The relationship sulfur has with zinc is evident when 
looking at zinc finger proteins where two of the four binding ligands are cysteines (131). Thiol 
ligands give zinc the ability to be thermodynamically stable while allowing fast ligand exchange 
through reversible redox reactions. A useful example of this dynamic is the interaction of zinc 
with metallothioneins, cysteine rich low molecular weight proteins. Zinc would be released from 
metallothioneins and transferred to sulfhydryl groups on oxidation susceptible proteins during 
oxidative stress to avoid oxidation (132). Metallothioneins also have the ability to cluster copper, 
maintaining biological metal homeostasis and providing protection from harmful molecules such 
as toxic heavy metals including mercury, lead and cadmium. Insufficient copper can lead to 
defective copper containing enzymes such as cytochrome c oxidase, dopamine hydroxylase or 
tyrosinase (133, 134). The contents and role of the metallothionein cluster depend on three 
factors, i) the source of the protein, ii) any previous exposure to metal ions, and iii) the primary 
sequence of the protein chain as it can partially select for specific metals (134). From toxic 
metals to metal ions required for normal function, sulfides have a natural function in the clearing 
or the transport of metal ions.  
Concentrating on nickel now, much research has been conducted with regards to nickel and 
sulfur’s chemical relationship. Much of the research focuses on H2S gas sensing and detection as 
a way to protect against the toxic effects of H2S (135, 136). Lee et al. discovered that sensors 
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promoted with nickel oxide were able to increase sensitivity down to 1 ppm with a high sensor 
response percentage. In a different type of study, nickel sulfide was found to improve structural 
stability during repeated sodium insertion and extraction processes in sodium-ion batteries (137). 
Exploring the role of nickel and H2S in cellular functions is innovative and novel, research has 
focused on the toxic effects of nickel at high concentrations in cells while pathophysiological 
concentrations and their effects with endogenous H2S has yet to be examined.  
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2 Hypothesis and objectives 
 
Nickel has been shown to induce the activation of fibroblast cells and lead to tissue fibrosis (138, 
139) and the beneficial roles of H2S in the progression of various tissue fibrosis have also been 
documented (140-142). However, the cross talk between nickel and endogenous H2S signaling 
system in fibroblast cell activation has not been investigated. Here it is hypothesized that 
endogenous H2S may protect nickel-induced fibroblast cell activation. To this end, two 
objectives are proposed: 1) to determine the effect of nickel on H2S signalling in human 
fibroblast cells; 2) to investigate the mediation of endogenous H2S signalling on nickel-induced 
fibroblast cell activation as well as the underlying mechanism. This project would provide an 
important potential target for the treatment of tissue fibrosis.  
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3 Methodology  
 
3.1  Cell culture and treatments  
Human fibroblast (HF) cells from skin tissue was purchased from American Type Culture 
Collection (Manassas, VA, USA). Experiments were conducted using (6-12) passages. The cells 
were recovered and maintained in Dulbecco's Modified Eagle's Medium (DMEM) (Sigma-
Aldrich, Oakville, ON, CA) supplemented with 10% fetal bovine serum (FBS) (Gibco, Thermo 
Fisher, USA) and 1% penicillin–streptomycin solution (Hyclone, Thermo Fisher, USA). The 
cells were kept in an incubator at 37 °C in a 5% CO2, 95% air atmosphere. 
Mouse embryonic fibroblast (MEF) cells were isolated from the embryos in both CSE knock out 
mice (MEF-KO) wild type littermates (MEF-WT) as described previously (143).  The cells were 
maintained in DMEM supplemented with 20% FBS and 1% penicillin–streptomycin solution, 
and (3-6) passages were used in this study. 
 
3.2  Cell viability and cell number 
Equal numbers of cells were seeded and grown to approximately 80% confluence and a gradient 
of treatments were incubated for 24 hours in 96 well plates. Briefly, the treatment was washed 
away by PBS and 3-[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) was 
added to each well and incubated at 37 °C for 4 hours. The reduction of the yellow MTT to dark 
blue/purple formazan, is done in the mitochondria, thus by living cells only (144). Formazan can 
be dissolved in DMSO, the solution was then read spectrophotometrically. The absorbance was 
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measured using a FLUOstar OPTIMA microplate spectrophotometer (BMG LABtech, Germany) 
at 570 nm. Cell viability was expressed as a percentage of untreated control cells. 
To further confirm the effects of cell viability, cells were removed by trypsinization and 
resuspended for cell number counting using a hemocytometer. 
 
3.3  Cell migration 
The cell’s ability to repair, regenerate and migrate was analyzed by scratch wound assay (145). 
Briefly medium was removed from post-confluent HF cells and they were subjected to a single 
pass with a medium sterile pipette tip causing a “wound”. Serum free medium and the treatments 
groups were added for 24 hours. Wound closure was monitored and pictures were taken using 
Olympus IX71 microscope and DP2-BSW computer software at times 0 and 24 hours. The 
migrated area of the cells was measured and analysed using Image J 1.43v software.  
 
3.4  Western blot  
Protein expression levels were tested by western blotting. After treatments, HF and MEF cells 
were collected and lysed in tris EDTA with sucrose buffer along with protease inhibitor (Sigma-
Aldrich, Oakville, ON, CA). The supernatant comprising cellular proteins was collected 
following centrifugation at 15 000 × g for 15 minutes. Proteins were denatured with heat and 
extracts were separated by a 10% SDS-PAGE and blotted onto nitrocellulose membranes (Pall 
Corporation, Pensacola, FL, USA) as previously described (146). Membranes were blocked in 
3% milk in PBS, next the membranes were probed with appropriate primary antibodies and 
detected using peroxidase-conjugated secondary antibodies 1:5000 (Sigma-Aldrich, Oakville, 
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ON, CA) and finally the signals were visualized by ECL (GE Healthcare, Amersham, UK). The 
dilutions of primary antibodies were: 1:5000 for β-actin (Sigma-Aldrich, Oakville, ON, CA), 
1:1000 for αSMA (Abnova, Taiwan), 1:1000 for CSE (Abnova, Taiwan), 1:1000 for CBS 
(Abnova, Taiwan), 1:1000 for 3-MST (Abnova, Taiwan), 1:200 for Sp1 (Santa Cruz 
Biotechnology, Santa Cruz, CA), and 1:200 for MMP2 (Santa Cruz Biotechnology, Santa Cruz, 
CA, USA),  1:200 for TGFβ1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), 1:1000 for 
SMAD1, SMAD2 and SMAD3 (Cell Signaling Technology Inc., Whitby, ON, CA). Bands were 
always normalized against the β-actin band. 
 
3.5   RNA extraction, reverse transcription and real-time PCR 
After treatments, the cells were collected and RNA was extracted using TRIzol reagent (Sigma-
Aldrich, Oakville, ON, CA). Following centrifuge at 12 000 × g for 15 minutes, the clear upper 
phase of the samples was transferred to new tubes and precipitated with isopropanol. Total RNA 
was reverse transcribed into cDNA using random hexamer primers according to manufacturer’s 
protocol (Thermo Fisher Scientific, Ottawa, ON, CA). Negative controls were prepared to ensure 
no DNA contamination was present (147). The quantification of mRNA expression was 
performed with an iCycler iQ5 apparatus (Bio-Rad, Mississauga, ON, CA) associated with the 
iCycler optical system software (version 3.1) using SYBR Green PCR Master Mix (Bio-Rad). 
The sequences of primers were: αSMA (5’-CCACTGCCGCATCCTCATCCT-3’ and 5’-
CCCGGCTTCATCGTATTCCTGTT-3’); fibronectin (5’-GGCTGCCCACGAGGAAATCT-3’ 
and 5’-GCCACGGCCATAGCAGTAGCAC-3’); CSE (5’-CCCCCATCTCACTGTCCACCAC-
3’ and 5’-CAGCCTTCAATGTCAATCACCTTC-3’); and GAPDH (5’-
GCGGGGCTCTCCAGAACATCAT-3’ and 5’-CCAGCCCCAGCGTCAAAGGTG-3’).  
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The cycling condition template started at 95°C followed by 38 cycles consisting of 95°C for 15 
seconds and 60°C for 60 seconds. A standard melting curve was performed by increasing the 
temperature to 95°C for 60 seconds, decreasing the temperature to 55°C and increasing the 
temperature by 1°C. Relative mRNA quantification was then calculated by using the formula 
2−ΔΔCT, where ΔCT is the difference between the threshold cycle of a given target cDNA and an 
endogenous reference of GAPDH gene. 
 
3.6 Thiol detection through fluorescence  
The cellular thiol contents was analyzed by a thiol detection assay kit (Cayman chemical, Ann 
Arbor, MI, USA). Briefly, equal amounts of protein was added into the well containing 50 µL 
thiol fluorometric detector. The plate was then incubated in the dark for 5 minutes. After that, the 
plate was read at excitation wavelength of 340 nm and an emissions wavelength of 520 nm using 
a FLUOstar OPTIMA reader and OPTIMA software (version 2.00R3). 
 
3.7  ROS detection 
After different treatment, the cells were first rinsed with PBS twice then incubated with 1 µg/mL 
of 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) (Invitrogen, Carlsbad, CA, USA) a 
fluorescence probe to visualize the presence of ROS in the cells (148). Images were obtained 30 
mins after the addition using Olympus IX71 microscope and DP2-BSW software. Image J 1.43 
software was used to quantify fluorescent intensity. 
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3.8  Immunofluorescence staining 
HF cells were grown, treated and then fixed with a 4% paraformaldehyde/PBS solution for 15 
minutes, the cells were permeabilized in a 50% acetone: 50% methanol solution after fixing. 
These cells were stained with anti-α-SMA antibody (Abnova, Taipei, 1:500) followed by FITC-
conjugated secondary antibody (Sigma-Aldrich, Oakville, ON, CA, 1:2000) (86). The 
immunoreactions were visualized though Olympus IX71 microscope and DP2-BSW software. 
 
3.9  Measurement of endogenous H2S production  
WT mouse liver and HF cell lysate were used for analysis of H2S production rate. The 
production rate was measured with a methyl blue method as previously described (41, 149). The 
flasks were mixed with 100 mM potassium phosphate buffer, 10 mM L-cysteine, 2 mM 
pyridoxal 5-phosphate, 10% (w/v) liver lysate, and various agents as indicated in the figures. 
Next, a center well containing 0.5 mL 1% zinc acetate and a 2 cm × 2.5 cm piece of filter paper 
were added to the reaction flask. The flasks were flushed with N2, sealed with Parafilm and then 
incubated at 37°C for 90 mins. The reaction was stopped by adding 50% trichloroacetic acid then 
the flasks were incubated again at 37°C for 60 mins. The contents of the center wells were 
transferred to test tubes containing 3.5 mL of water. Then, 0.5 mL of both 20 mM N,N-dimethyl-
p-phenylenediamine sulfate in 7.2 M HCl and 30 mM FeCl3 in 1.2 M HCl were added to the test 
tube to produce methylene blue. The test tubes were incubated at room temperature for 20 mins 
and the solution was measured spectrophotometrically at 670 nm using a FLUOstar OPTIMA 
microplate spectrophotometer. The amount of H2S was calculated against an H2S standard curve 
and expressed in nmole/g/min. 
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3.10 H2S direct chemical interaction 
The direct interaction of H2S with NiCl2, fibronectin, collagen and TGFβ1 was analyzed with a 
lead sulfur method (150). The solution containing NaHS with or without NiCl2, fibronectin, 
collagen and TGFβ1 at the concentrations as indicated in the figures was placed in a 96-well 
plate. Lead acetate paper (Sigma-Aldrich, Oakville, ON, CA) was secured above the liquid phase 
contained in the 96-well plate with a cover. The reaction was incubated for 1 hour at 37°C in the 
dark. H2S gas was released and reacted with the paper forming yellow-brown color. The well 
only containing NaHS acted as the control. The lead acetate paper was then scanned and the 
colour change was analyzed with Image J software. 
 
3.11 Sp1 gene transfection  
Sp1 gene was transfected into HF as described previously (86). Briefly 1 μg of pcDNA3.1-Sp1 
vector or pcDNA3.1-control vector was transfected into HFs with lipofectamine 2000 
(Invitrogen Carlsbad, CA, USA). The cells were incubated with the vectors for a total for 24 
hours therefore 0.2 mM NiCl2 was added for additional 24 hours. The cells were then harvested 
and lysed, and the protein expressions of Sp1, CSE, and TGFβ1 were measured with western 
blotting. 
 
3.12 Chromatin immunoprecipitation (ChIP)  
To determine the direct interaction of nickel on Sp1 binding with the promoters of CSE and 
TGFβ1, a ChIP assay was conducted. After different treatments, the cells were treated with 
paraformaldehyde to crosslink protein and DNA interactions and nuclear material was extracted 
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from the cells. Next the antibody against Sp1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
was added to precipitate Sp1 antigen. After purification, the Sp1 protein was then removed by 
protease leaving only the DNA fragments that was bound to Sp1 transcription factor (151). The 
intensity of Sp1-binding DNA region was then determined by real-time PCR. PCR primers 5′- 
GGACTCCAGCTTCACTCCGCTT-3′ (forward) and 5′- TTAGCGGGTCTGCAGTCTCACG-
3′ (reverse) were used to amplify Sp1 binding site in human CSE promoter (86). PCR primers 5′-
CCCCGCGAGGAGGCAGGAC-3′ (forward) and 5′-TCAGGGAGAAGGGCGCAGTGGTG-3′ 
(reverse) were used to amplify Sp1 binding site in human TGFβ1 promoter. The binding 
intensity of Sp1 with gene promoters was normalized to the level of input. Input is the nuclear 
material that was extracted from the cell without the addition of the antibody in the purification 
step. 
 
3.13 Fluorescent detection of labile zinc 
FluoZin-3-AM (Invitrogen, Carlsbad, CA, USA) is a specific fluorometric detector for 
visualization of labile zinc (152). After different treatments, HF cells were washed three times 
with PBS and incubated with 1 μM FlouZin-3-AM for 1 hour and 24 hours at 37°C. The cells 
were then rinsed three times with PBS, the fluorescence signals were detected using an inverted 
Olympus IX70 fluorescence microscope. Then, Image J 1.43 software was used to quantify 
fluorescent intensity. 
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3.14 Statistical analysis 
All results were presented as means ± SEM, representing at least 3 independent experiments. 
Statistical comparisons were made using two-tailed Student's t-tests or one-way ANOVA 
followed by a post-hoc analysis (Tukey test) where applicable. Values of p<0.05 were 
considered to be statistically significant. 
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4 Results  
 
4.1  H2S blocks nickel-stimulated cell migration 
The effect of increasing concentrations of nickel on HF viability was first determined. As 
illustrated in figure 4.1.1, nickel at concentration higher than 1 mM started to inhibit cell 
viability, and 5 mM nickel reduced cell viability by more than 80%. However, the cell viability 
was increased by nickel at low concentration. In comparison with the control cells, nickel at 0.1 
mM and 0.2 mM significantly induced cell viability by 16% and 15%, respectively. Since this 
study focuses on effect of nickel in fibroblast cell activation at low doses, 0.2 mM NiCl2 was 
chosen in later experiments. We next evaluated the interaction of nickel and H2S on cell 
viability, cell number and cell migration. NaHS is used as a quick H2S-releasing donor, when 
dissolved in solution at pH 7.0, about one third NaHS becomes H2S gas. In the present study, 
anhydrous NaHS at 30 µM was added into the culture medium, which releases about 10 µM H2S 
within hours. The endogenous H2S concentration has been reported to high nano-molar to low 
micro-mole range, the concentration of H2S used here is physiological relevant. The supplement 
of NaHS (30 µM) had no effect on nickel (0.2 mM)-induced cell viability and cell number 
(figure 4.1.2 and figure 4.1.3); however NaHS significantly inhibited nickel (0.2 mM)-stimulated 
cell migration (figure 4.1.4). NaHS (30 µM) alone had no effect on cell viability, cell number 
and cell migration.  
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Figure 4.1.1    Effect of nickel on HF cell viability. HF cells were incubated with NiCl2 at the indicated 
concentrations for 24 hours. Cell viability was measured following treatments by MTT assay. * p<0.05 versus 
control. n =4 
 
 
Figure 4.1.2     The interaction of nickel and H2S on HF cell viability. HF cells were incubated with 0.2 mM 
NiCl2 with and without 30 µM NaHS for 24 hours. Cell viability was measured following treatments by MTT assay. 
* p<0.05 versus control. n = 3 
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Figure 4.1.3     Effect of nickel and H2S on HF cell number. Equal numbers of cells were seeded and grown. After 
24 hours of treatment, cells were trypsinized and counted using hemocytometer. * p<0.05 versus control. n =3 
 
 
 
Figure 4.1.4     Effect of nickel and H2S on HF cell migration. HF cells were grown post-confluence, wounding 
was induced by a single pass with a sterile pipette tip. Serum-free medium and treatments were added for 24 hours. 
Scale bar: 50 µm *, p<0.05 versus all other groups. n = 3 
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4.2  H2S reverses nickel-induced fibroblast cell activation  
Quiescent HFs have elongated, spindle and flat shapes, and when grow in a crowd, the cells tend 
to align in parallel. Exposure of HFs to 0.2 mM NiCl2 for 24 hours caused morphological 
alterations, and the cells became shorter and had higher contractility (figure 4.2.1). Interestingly, 
co-incubation of HFs with NaHS for 24 hours at 30 µM reversed nickel-altered cell morphology. 
A marker of fibroblast cell activation is the increased expression of αSMA. Nickel treatment 
significantly induced the expression of αSMA, as demonstrated by immunofluorescence (figure 
4.2.2), western blotting (figure 4.2.3), and real-time PCR (figure 4.2.4). Nickel also dramatically 
stimulated the mRNA expression of fibronectin, a gene responsible for generating a glycoprotein 
of the extracellular matrix (figure 4.2.5). Exogenously applied NaHS completely restored the 
expressions of αSMA and fibronectin induced by nickel, indicating a protective role of H2S 
against nickel-induced fibroblast cell activation. By using MEFs isolated from WT mice and 
CSE-KO mice, we also found that deficiency of CSE worsen nickel-induced expressions of 
αSMA (figure 4.2.6).  
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Figure 4.2.1     Morphology change of HF cells after nickel treatment. The cells were incubated with 0.2 mM 
NiCl2 in the presence or absence of NaHS (30 µM) for 24 hours. Scale bar: 20 µm. n = 3 
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Figure 4.2.2    αSMA immunostaining in nickel-treated HF cells.  After 24 hours of treatment with 30 µM NaHS 
and/or 0.2 mM NiCl2, the cells were fixed and subjected to αSMA staining. Scale bar: 20 µm. n =3 
 
 
 
Figure 4.2.3     Effect of nickel on αSMA protein expression. The cells were incubated with 0.2 mM NiCl2 in the 
presence or absence of NaHS (30 µM) for 24 hours. The cells were collected, lysed and protein was isolated in the 
presence of protease inhibitor followed by western blotting analysis of αSMA and β-actin. n = 3. 
 
 
Figure 4.2.4    Effect of nickel on αSMA mRNA expression. The HF cells were treated with 0.2 mM NiCl2 in the 
presence or absence of NaHS (30 µM) for 24 hours. The cells were collected, mRNA was isolated and the 
expression of αSMA was detected by real-time PCR. *, p<0.05 versus all other groups. n = 3 
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Figure 4.2.5     Effect of nickel on fibronectin mRNA expression in HF cells. After 24 hours of treatment with 30 
µM NaHS and/or 0.2 mM NiCl2, the cells were collected for detection of mRNA expression by real-time PCR. *, 
p<0.05 versus all other groups. n =3 
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Figure 4.2.6     Effect of CSE deficiency on αSMA protein expression. Both WT-MEFs and KO-MEFs were 
incubated with 0.2 mM NiCl2 for 24 hours. The cells were collected and lysed, and protein expressions were 
analyzed by western blotting. *, p<0.05 versus WT-MEF control; #, p<0.05 versus all other groups. n =3  
 
4.3  Nickel inhibits CSE expression and blocks H2S production 
We then examined the effect of nickel on the expressions of three H2S-generating enzymes. 
Incubation of HFs with 0.2 mM NiCl2 for 24 hours significantly inhibited CSE protein 
expression but had no effect on CBS protein expression (figure 4.3.1). The protein expression of 
3-MST was not detected in HF cells. CSE mRNA expression was also suppressed by nickel as 
demonstrated by real-time PCR assay (figure 4.3.2). Furthermore, nickel reduced H2S production 
rate by 66.7% in comparison with the control cells, pointing to an inhibitory role of nickel on 
CSE enzymatic activity (figure 4.3.3). To observe whether nickel can also directly react with 
H2S, we mixed NiCl2 and NaHS, which was then exposed to lead acetate paper. As shown in 
figure 4.3.4, there was clear evidence that nickel scavenged H2S by direct chemical interaction. 
All these data indicate that nickel inhibits CSE/H2S system at different levels, at the transcription 
level of CSE mRNA, inhibiting CSE enzymatic activity, and directly trapping H2S.  
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Figure 4.3.1     Effect of nickel on the protein expression of H2S-producing enzymes. HF cells were incubated 
with 0.2 mM NiCl2 for 24 hours. The cells were collected and protein was isolated followed by western blot analysis 
of CSE, CBS and 3-MST. β-actin was used as a house keeping gene for normalization. n = 4  
 
 
Figure 4.3.2     Effect of nickel on CSE mRNA expression. The HF cells were treated with 0.2 mM NiCl2 in the 
presence or absence of NaHS (30 µM) for 24 hours. The cells were collected, mRNA was isolated and the 
expression of αSMA was detected by real-time PCR. *, p<0.05. n = 4 
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Figure 4.3.3     Effect of nickel on H2S production rate in HF cells. H2S production rate was measured with 
methyl blue method. *, p<0.05. n =4 
 
Figure 4.3.4     The direct interaction between H2S and nickel. Direct interaction was measured using acetate lead 
paper. NiCl2 (0.2 mM) and NaHS (30 µM) were mixed together followed by detection of H2S release at 37°C for 1 
hour. The intensity of the colour was proportional to the amount of H2S produced. *, p<0.05. n =4 
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4.4  Nickel depletes thiol content and enhances oxidative stress 
 
After 24 hours of incubation with nickel, the intracellular thiol contents were depleted by 45.5%, 
which was restored to normal level by exogenously applied NaHS. NaHS alone slightly but 
significantly stimulated thiol contents in HFs (figure 4.4.1). ROS is believed to be an important 
component in nickel-induced fibroblast cell activation, consequently, we investigated ROS 
generation in nickel-treated cells. In contrast to the control cells, nickel significantly stimulated 
the generation of intracellular ROS, which was effectively attenuated by NaHS co-incubation 
(figure 4.4.2).  
 
 
Figure 4.4.1     Effect of nickel on the thiol content in HF cells. HFs were incubated with 0.2 mM NiCl2 with or 
without NaHS (30 µM) for 24 hour, the cells were collected for detection of intracellular thiol contents by detection 
kit using a proprietary fluorometric detector that reacts with thiol groups to emit a fluorescent signal. (AU: arbitrary 
unit). *, p<0.05 versus all other groups; #, p<0.05 versus control. n =4 
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Figure 4.4.2     Effect of nickel on ROS in HF cells. After incubation with 0.2 mM NiCl2 with or without NaHS (30 
µM) for 24 hour, the cells were incubated with H2DCFDA for 30 minutes to detect ROS. Scale bar: 20 µm. n = 4 
 
4.5 Involvement of TGFβ1/SMAD1 in nickel-induced fibroblast cell activation 
TGFβ1 is one of the major pro-fibrotic cytokines and has been identified as a core pathway of 
fibrosis. As a result, we next investigated whether the protective effects of H2S on nickel-induced 
fibroblast cell activation is related to TGFβ1. Nickel treatment of the cells induced the 
expressions of TGFβ1 and SMAD1, but had no effect on SMAD2 and SMAD3. Exogenously 
applied NaHS blocked the stimulatory role of nickel on TGFβ1 and SMAD1 expression (figure 
4.5.1). We further validated that TGFβ1 promoted the protein expressions of αSMA and SMAD1 
(figure 4.5.2), and the mRNA expression of αSMA (figure 4.5.3) and fibronectin (figure 4.5.4), 
all of which were partially reversed by NaHS co-incubation.  
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Figure 4.5.1     Effect of nickel on components of the SMAD pathway in HF cells. Cells were treated with NiCl2 
(0.2 mM) and or NaHS (30 µM) for 24 hours. The cells were collected and protein was isolated followed by western 
blot analysis of TGFβ1, SMAD1, SMAD2, and SMAD3. β-actin was used for normalization as a house keeping 
gene. n =3  
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Figure 4.5.2     Effects of TGFβ1 on αSMA and SMAD1 protein expression in HF cells. Cells were treated with 
TGFβ1 (10 ng/mL) and or NaHS (30 µM) for 24 hours. The cells were collected and protein was isolated followed 
by western blot analysis of αSMA and SMAD1 expression levels. β-actin was used as a house keeping gene for 
normalization. n =4  
 
Figure 4.5.3     Real-time PCR analysis of αSMA mRNA expression in TGFβ1-treated cells. The HF cells were 
treated with 10 ng/mL TGFβ1 in the presence or absence of 30 µM NaHS for 24 hours. The cells were collected, 
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mRNA was isolated and the expression of αSMA was detected by real-time PCR. *, p<0.05 versus all other            
groups. n =3 
 
 
 
Figure 4.5.4     Effect of TGFβ1 on fibronectin mRNA expression in HF cells. After 24 hours of treatment with 
30 µM NaHS and/or 10 ng/mL TGFβ1, the cells were collected for detection of fibronectin mRNA expression by 
real-time PCR. *, p<0.05 versus all other groups. n =3 
 
TGFβ1 also dose-dependently induced cell viability, which was not affected by NaHS (figure 
4.5.5). In contrast, NaHS blocked the stimulatory role of TGFβ1 on cell migration (figure 4.5.6). 
TGFβ1, fibronectin and type I collagen had no effect on H2S production rate and did not 
chemically react with H2S (figure 4.5.7 and 4.5.8).  
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Figure 4.5.5     Effects of TGFβ1 and NaHS on HF cell viability. HF cells were incubated with TGFβ1 and NaHS 
at the indicated concentrations for 24 hours. Cell viability was measured following treatments by MTT assay. * 
p<0.05 versus control. n =4 
 
 
 
Figure 4.5.6     Effects of TGFβ1 and NaHS on HF cell migration. HF cells were grown post-confluence, 
wounding was induced by a single pass with a pipette tip. Serum –free medium and TGFβ1 (10 ng/mL) and NaHS 
(30 µM) treatments were added for 24 hours. Scale bar: 50 µm *, p<0.05 versus all other groups. n = 3 
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Figure 4.5.7     Effect of ECM components on H2S production rate.. Liver tissues from WT mice were used for 
measurement of H2S production rate by methyl blue method. Treatment groups included TGFβ1, fibronectin, and 
collagen at the noted concentrations. n =4 
 
Figure 4.5.8     Measurement of the direct interaction between H2S and ECM constituents. Direct interaction 
was measured using acetate lead paper. Fibronectin (1 µM), collagen (1µM) or TGFβ1 (10 ng/mL) was mixed with 
NaHS. Followed by detection of H2S released at 37°C for 1 hour. n =3 
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Altered expression and activation of MMPs are often involved in fibroblast cell activation, 
however we found that the protein expression of MMP2 was not changed by either nickel or H2S 
(figure 4.5.9). The three members of MAPK (ERK1/2, p38, and JNK) were also not affected by 
nickel treatments as seen in figure figure 4.5.10. 
 
 
Figure 4.5.9     Effect of nickel on MMP2 protein expression in HF cells. The cells were incubated with 0.2 mM 
NiCl2 and/or 30µM of NaHS for 24 hours. The cells were collected and protein was isolated followed by western 
blot analysis of MMP2. β-actin was used as a house keeping gene for normalization. n =3  
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Figure 4.5.10     Effect of nickel on members of MAPK pathway. HF cells were incubated with 0.2 mM NiCl2 and 
at the given times. The cells were collected and protein was isolated followed by western blot analysis of p-ERK 
1/2, p-p38, and p-JNK. β-actin was used as a house keeping gene for normalization. n=3  
 
4.6 The interaction of nickel and H2S in mobilizing intracellular labile zinc and altering 
Sp1 transactivation  
Sp1, a transcription factor with a DNA binding domain composed of three zinc fingers, has been 
proven to bind to GC-rich motifs in the promoters of both CSE and TGFβ1 genes. To explore 
whether nickel changes the transactivation of Sp1, Sp1 cDNA was transfected into HFs. As 
expected, Sp1 overexpression stimulated the protein expressions of both CSE and TGFβ1. The 
addition of nickel did not change Sp1 expression but differentially alter the regulatory role of 
Sp1 on CSE and TGFβ1 expression. In the presence of nickel, Sp1 further strengthened TGFβ1 
expression but lost its stimulatory role on CSE expression (figure 4.6.1). By using ChIP assay as 
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shown in figure 4.6.2, we then observed that nickel attenuated the binding of Sp1 with CSE 
promoter but enhanced the binding of Sp1 with TGFβ1 promoter, which were completely 
reversed by the supplement of NaHS. NaHS alone had no effect on the interaction of Sp1 with 
CSE and TGFβ1 promoters. As Sp1 binds directly to DNA via its zinc finger protein motif and 
nickel can compete with zinc to bind with protein, we then investigated whether nickel would 
alter intracellular labile zinc. By using a zinc-sensitive fluorophore, FluoZin-3, we observed that 
nickel incubation of the cells for 1 hour or 24 hour slightly induced the fluorescent intensity of 
intracellular zinc, although it did not reach statistical significance (figure 4.6.3). The supplement 
of NaHS showed no effect on intracellular labile zinc.   
 
 
Figure 4.6.1     Effect of nickel on Sp1, CSE and TGFβ1 protein expression in Sp1-transfected HF cells. The 
cells were transfected with Sp1 cDNA for 24 hours, NiCl2 (0.2 mM) was added for another 24 hours. The cells were 
collected and protein was isolated followed by western blot analysis of Sp1, CSE and TGFβ1. β-actin was used as a 
house keeping gene for normalization. *, p<0.05 versus control or NiCl2 group. #, p<0.05 versus Sp1 group. n=3  
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Figure 4.6.2     ChIP assay analysis of Sp1 binding with CSE and TGFβ1 promotor. After the cells were treated 
with NiCl2 (0.2 mM) and/or NaHS (30 µM) for 24 hours, the cells were processed for ChIP assay with the antibody 
against Sp1. Then the interaction between Sp1 and the promoter was quantitatively analysed by real-time PCR. The 
binding images were shown in the left panel, and quantitative analysis by real-time PCR as shown in right panel. * 
p<0.05 versus all other groups. n = 3  
 
Figure 4.6.3     Effect of nickel on labile zinc in HF cells. The cells were treated with 0.2 mM NiCl2 and/or NaHS 
(30 µM) for 1 hour and 24 hours. Cells were incubated with a zinc-sensitive fluorophore, FluoZin-3 and 
fluorescence was measured. AU: arbitrary unit Scale bar: 20 µm. n = 3 
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5 Discussion  
Nickel was classified as a toxic compound by the International Agency for Research on Cancer 
in 1990 (111, 118, 153). Animal and human exposure to nickel lead to abnormal metabolic 
processes and have increased risk of various organ disorders (153, 154). Bioaccumulation of 
intracellular nickel can disrupt protein structure and alter enzyme activity by preferentially 
binding to sulfur-containing groups in specific amino acids (118, 155). Nickel also can crosslink 
with nucleotides and impair gene replication, transcription and DNA damage repair (111). One 
of the detrimental effects of nickel is to cause fibrogenesis and tumorigenesis by inducing 
epithelial-mesenchymal transition (EMT) (156). The present study validated that nickel exposure 
to human fibroblasts promoted their activation, as evidenced by morphological alterations, 
increased cell growth, migration, and higher expressions of αSMA and fibronectin, all of which 
are typical features of EMT and are closely associated with the pathogenesis of tissue fibrosis.  
Interestingly, traditionally known as a noxious and toxic gas but now recognized as a new 
gasotransmitter, H2S was found to be a target of nickel-induced fibroblast activation. We first 
found nickel incubation of the cells reduced the mRNA and protein expression of CSE, a major 
H2S-generating enzyme in fibroblasts. Although CBS (another H2S-generating gene) was also 
expressed in fibroblasts, it seemed that nickel had no effect on CBS expression. Moreover, nickel 
directly blocked the enzyme activity of CSE with an unknown mechanism. We further confirmed 
that nickel was able to react with H2S gas and reduced its release from NaHS solution. All these 
suggest the inhibitory role of nickel on CSE/H2S system, pointing to the possibility of the 
mediation of H2S in nickel-induced fibroblast activation. Indeed, supplement of H2S reversed but 
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complete knockout of CSE enhanced the pro-fibrotic effect of nickel. It is worth noting that 
numerous studies have demonstrated the protective role of H2S in the development of fibrosis in 
lung, liver, kidney, and heart, etc (141, 142). The protective role of H2S against heavy metal-
induced damage have also been reported in many other cell types. H2S reacted directly with 
methylmercury to form a less toxic metabolite and attenuated methylmercury-induced 
neurotoxicity via the inhibition of oxidative stress and protection of mitochondria (157, 158). 
H2S attenuated uranium-induced acute nephrotoxicity through oxidative stress and inflammatory 
response via Nrf2-NF-κB pathways (159). H2S was also involved in homocysteine-prevented 
lymphocyte viability loss by cobalt (160). 
To investigate the mechanisms underlying H2S-protected fibroblast cell activation by nickel, we 
looked at the TGFβ/SMAD pathways. It is well known that TGFβ, through both SMAD-
dependent and SMAD-independent mechanisms, is a major driver in promoting the expressions 
of αSMA and ECM-generating genes, leading to the transformation of fibroblasts into 
myofibroblasts and excessive accumulation of ECM (67). Nickel increased the expression of 
TGFβ1 and SMAD1 but had no effect on SMAD2 and SMAD3 as well as the phosphorylation of 
ERK1/2, p38, and JNK, indicating only TGFβ1/SMAD1 is responsible for the induction of 
αSMA and fibronectin. We further found that the addition of TGFβ1 stimulated SMAD1 
expression following enhanced expression of αSMA and fibronectin. TGFβ1 also induced cell 
migration. All these effects were blocked by exogenously applied H2S, suggesting the 
involvement of CSE/H2S signal in nickel-promoted TGFβ1/SMAD1 signals. TGFβ1 is also 
involved in the expression of MMP capable of degrading ECM (100); however our data showed 
that MMP2 was not affected by either nickel or H2S. MMPs are a family of zinc-dependent 
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endopeptidases, it is possible that nickel/H2S would change MMP2 enzymatic activity by 
disturbing zinc affinity toward to MMP2 protein, which deserves to be further tested. 
Generation of oxidative stress are often reportedly contributed to nickel toxicity and fibrogenesis 
(161, 162). Here we proved that nickel treatment of cultured cells oxidized dichlorofluorescin to 
a fluorescent product and induced the level of oxidants in the cells. The higher level of ROS by 
nickel may be due to the low level of thiol, since nickel significantly lowered the contents of 
intracellular thiol. Thiol, a sulphydryl (SH) group-containing compound, plays significant roles 
in defense against oxidative stress (163, 164). Nickel has high affinity to interact with thiols by 
forming planar complexes. It has been reported that mutation of cysteine 295 in carbon 
monoxide dehydrogenase-II resulted in the decrease of nickel content and N-acetyl cysteine 
attenuated nickel-induced production of ROS (165, 166). H2S was able to increase glutathione 
level by stimulating the expressions of GSH-synthesizing genes (151). H2S also reduced the 
disulfide-bond inside protein by forming S-sulfhydration (167). By competing with nickel to 
bind with SH-containing thiol compounds, H2S would eventually diminish the inhibitory role of 
nickel on the level of total thiols.  
Nickel suppressed CSE expression but induced TGFβ1 expression. It is not clear how nickel 
differentially affects CSE and TGFβ1. Sp1, a transcription factor with three contiguous Cyseine2-
Histidine2 zinc finger domains, regulates gene transcription by binding to GC-rich motifs of 
many promoters (168). We and others demonstrated that both CSE and TGFβ1 acted as 
downstream genes of Sp1 (35, 85, 86). Nickel had no effect on Sp1 expression, however nickel 
blocked the stimulatory role of Sp1 on CSE expression and further strengthened the stimulatory 
of Sp1 on TGFβ1 expression. These effects were attributed to the different role of nickel in 
altering the interaction of Sp1 with CSE and TGFβ1 promoters. Excess or deficiency of divalent 
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zinc impairs DNA binding of Sp1 (168, 169). Nickel alters the activities of zinc-containing 
proteins/enzymes through mobilization of intracellular zinc, which can be further strengthened 
by chelating zinc, pointing to an important role of zinc in antagonizing the effect of nickel (170). 
Zinc fingers are reactive towards nickel, with zinc/nickel substitution and the oxidation of 
cysteine residue(s) in zinc fingers as major reactions (170, 171). So the zinc in Sp1 zinc-finger 
domains are susceptible to nickel hydrolysis due to the nickel over-accumulation inside the cells. 
Previous studies have shown that nickel substitution of zinc in Sp1 altered Sp1 binding sequence 
by changing the conformation of Sp1 DNA-binding domain (169, 171). Although the change of 
total labile zinc by nickel was not significant, it does not exclude the possibility that individual 
protein (such as Sp1) can be targeted by nickel to replace zinc or nickel can bind with the protein 
without affecting zinc crosslink with the protein. Nickel exposure can selectively damage Sp1 
interaction with gene promoters, which initiates the pro-fibrotic activity of nickel compounds 
(169). H2S S-sulfhydration modification of proteins by forming a –SSH bond with the target 
cysteine residues, and Sp1 has been reported to be one target for H2S S-sulfhydration (172). 
Based on these evidence, it can be speculated that, the supplement of H2S reverses the effects of 
nickel on Sp1 transactivation by promoting the structure stability of zinc-finger domains, while 
reduced level of H2S due to low expression of CSE promotes the pro-fibrotic effect of nickel.  
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6 Conclusion  
Taken together, our results demonstrated that nickel at low concentration acts as a pro-fibrotic 
molecule by altering Sp1 transactivation, inhibiting the CSE/H2S system, activating 
TGFβ1/SMAD1 pathway, upregulating the expressions of αSMA and fibronectin, and reducing 
intracellular thiols (Fig. 6.1). Supplement of H2S donor was sufficient to reverse the stimulatory 
role of nickel on fibroblast cell activation. Future studies aim at dissecting the role of H2S in 
protecting tissue fibrosis by nickel and/or other heavy metals in animals and human. 
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Figure 6.1     Proposed mechanism underlying H2S protection against nickel induced fibroblast activation. 
Nickel acts as a pro-fibrotic molecule by altering Sp1 transactivation, inhibiting the CSE/H2S system, activating 
TGFβ1/SMAD1 pathway, upregulating the expressions of αSMA and fibronectin, inducing cell migration, 
upregulating ECM production attributing to tissue fibrosis. Nickel also attenuates intracellular thiols consequently 
increasing ROS leading to damage and tissue fibrosis. Supplement of H2S donor was able to reverse the stimulatory 
role of nickel on TGFβ1/SMAD1 activation and protects the cells from the effect of nickel on thiol levels. H2S 
demonstrated no effect on MMP2 proteins.  
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7 Limitation of this study and future work 
The present study was undertaken to determine the interaction of H2S and nickel in fibroblast 
cells and investigate the potentially protective role of CSE/H2S system in nickel-induced 
fibroblast cell activation as well as the underlying mechanism. One limitation of this study is it 
was only observed in cultured fibroblast cells, whether the results are widely applicable still 
needs to be tested in other mammalian cells and also in whole animals. The deletion of CSE gene 
led to significant suppression of endogenous H2S production and caused hypertension and 
atherosclerosis in mice. CSE knockout mice would be a good model to further determine the 
protective role of endogenous H2S against nickel toxicity.  
This study focused on the effects of exogenous H2S by using a fast-releasing H2S donor, NaHS. 
When NaHS is added into the culture media, only one third H2S is released in seconds and the 
concentration of remaining H2S is far less, as expected, within hours. Slow and stable releasing 
donors for H2S, such as GYY4137 and sulforaphane, can be further examined. 
There are still many gaps in the knowledge base that needs to be filled to fully understand the 
mechanisms. Further investigation of the molecular mechanisms underlying the roles of 
CSE/H2S system in regulating the TGFβ1/SMAD pathway and fibroblast cell activation will 
facilitate the development of novel therapies for the treatment of tissue fibrosis. In addition to 
TGFβ1/SMAD signaling, other pathways may also mediate the regulatory role of H2S in nickel-
induced fibroblast activation, which needs to be explored. S-sulfhydration is proposed to be the 
main mechanism for H2S signaling. It is worthy of further testing to see whether these 
downstream molecules act as targets by H2S for S-sulfhydration. 
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